EPCAM and ovarian carcinoma: Zhao et al. [268] showcased the efficacy of a microfluidic nanoprobe to demonstrate that circulating exosome CD24, epithelial cell adhesion molecule (EpCAM) and folate receptor α (FRα) markers can be quantitatively detected using only 2 μl plasma to detect ovarian cancer.